期刊
CELL DEATH AND DIFFERENTIATION
卷 18, 期 5, 页码 754-768出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/cdd.2010.143
关键词
amyotrophic lateral sclerosis; interferon-gamma; LIGHT; astrocytes; motoneurons
资金
- PACA conseil regional - Trophos SA Ph.D fellowship
- Institut National de la Sante et de la Recherche Medicale (Inserm)
- Association Francaise contre les Myopathies (AFM)
- Association Francaise pour la Recherche sur la SLA (ARS)
- Thierry Latran foundation
Amyotrophic lateral sclerosis (ALS) is an incurable neurodegenerative disease that primarily affects motoneurons in the brain and spinal cord. Dominant mutations in superoxide dismutase-1 (SOD1) cause a familial form of ALS. Mutant SOD1-damaged glial cells contribute to ALS pathogenesis by releasing neurotoxic factors, but the mechanistic basis of the motoneuron-specific elimination is poorly understood. Here, we describe a motoneuron-selective death pathway triggered by activation of lymphotoxin-beta receptor (LT-beta R) by LIGHT, and operating by a novel signaling scheme. We show that astrocytes expressing mutant SOD1 mediate the selective death of motoneurons through the proinflammatory cytokine interferon-gamma (IFN gamma), which activates the LIGHT-LT-beta R death pathway. The expression of LIGHT and LT-beta R by motoneurons in vivo correlates with the preferential expression of IFN gamma by motoneurons and astrocytes at disease onset and symptomatic stage in ALS mice. Importantly, the genetic ablation of Light in an ALS mouse model retards progression, but not onset, of the disease and increases lifespan. We propose that IFN gamma contributes to a cross-talk between motoneurons and astrocytes causing the selective loss of some motoneurons following activation of the LIGHT-induced death pathway.Cell Death and Differentiation (2011) 18, 754-768; doi:10.1038/cdd.2010.143; published online 12 November 2010
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据